» drug price regualtor News

drug price regualtor

Cipla, Lupin, Glenmark other pharma stocks stuck in narrow range after NPPA revises price of 25 drug formulations

Cipla, Lupin, Glenmark other pharma stocks stuck in narrow range after NPPA revises price of 25 drug formulations

Tue, Mar 28, 2023

Pharma stocks were a mixed bag on Tuesday, as Sun Pharma, Lupin, Biocon, Aurobindo Pharma, Pfizer, Granules and Glaxosmith succumbed to selling pressure, and Cipla, Natco Pharma, Glenmark, Dr Reddy, Abbott India and Ipca Labs managed to eke out gains. Drug pricing regulator NPPA fixed retail prices of 25 formulations. 

More >

TRENDING NOW

EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know

EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know

Tamil Nadu Weather News: Heavy rain likely in TN, orange alert issued for Nov 26

Tamil Nadu Weather News: Heavy rain likely in TN, orange alert issued for Nov 26

Top 7 Mutual Funds With Highest Returns in 10 Years: Rs 10 lakh investment in No 1 scheme has turned into Rs 79,46,160 in 10 years

Top 7 Mutual Funds With Highest Returns in 10 Years: Rs 10 lakh investment in No 1 scheme has turned into Rs 79,46,160 in 10 years

PSU stocks to BUY: Brokerage bets on these 2 largecap stocks for up to 36% return - Do you own?

PSU stocks to BUY: Brokerage bets on these 2 largecap stocks for up to 36% return - Do you own?

Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404

Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x